10.1371/journal.pone.0139377.t005 Tian-Xiao Li Tian-Xiao Li Bu-Lang Gao Bu-Lang Gao Dong-Yang Cai Dong-Yang Cai Zi-Liang Wang Zi-Liang Wang Liang-Fu Zhu Liang-Fu Zhu Jiang-Yu Xue Jiang-Yu Xue Wei-Xing Bai Wei-Xing Bai Ying-Kun He Ying-Kun He Li Li Li Li Disabling or fatal stroke rate within and beyond 30 days in the SAMMPRIS study. Public Library of Science 2015 intracranial atherosclerotic stenosis lt ias stroke rate hemorrhagic stroke rate intracranial Wingspan stenting Single Medical Center PurposeTo 433 Patients Treated basilar artery area perioperative stroke rate MethodsBetween July 2007 2015-09-30 03:08:16 Dataset https://plos.figshare.com/articles/dataset/_Disabling_or_fatal_stroke_rate_within_and_beyond_30_days_in_the_SAMMPRIS_study_/1560373 <p>Note:</p><p><sup>#</sup> The disabling or fatal stroke rates within 30 days could be found in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.t003" target="_blank">Table 3</a> in reference <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.ref008" target="_blank">8</a>.</p><p>* The disabling or fatal stroke rates at the end of 32.4 months of follow-up for both groups could be found in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.t003" target="_blank">Table 3</a> in reference <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.ref009" target="_blank">9</a>.</p><p>** The number of patients with disabling or fatal stroke beyond 30 days was 21–16 = 5 for the PTAS group but 18–4 = 14 for the MED group, whereas the number of patients who finished the follow-up was 191 for the PTAS group and 210 for the MED group (see the Results of reference <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.ref009" target="_blank">9</a>). PTAS: percutaneous transluminal angioplasty and stenting; MED: medical management group.</p><p>Disabling or fatal stroke rate within and beyond 30 days in the SAMMPRIS study.</p>